2017-10-17 15:01:03 UTC

Important Opportunity to Advise CMS on Colonoscopy Episode

Oct. 26, 2017

It is critical that you share your feedback with CMS by Wednesday, Nov. 15.

The Centers for Medicare & Medicaid Services (CMS) needs your feedback on a Screening/Surveillance Colonoscopy episode-based cost measure that is being evaluated for inclusion in the Merit-Based Incentive Payment System (MIPS) which affects your Medicare reimbursement. 

This is an important opportunity for you to provide feedback to help ensure the cost measure is meaningful for gastroenterologists. It is designed to compare your costs to those of other providers for the same service. 

AGA, ACG and ASGE assisted in the development of this cost measure. Together, our societies will continue to ensure that implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) is transparent and fair.  

Get Started
You can participate via an online survey through Nov. 15, 2017.  
 
View the draft materials that are subject to comment here. Use the resources below to facilitate your review of the draft materials:
Access Your Test Report
Physician-specific test reports are available through the CMS Enterprise Portal if you/your practice had at least 10 screening/surveillance colonoscopy episodes during the measurement period of June 1, 2016, to May 31, 2017. 
 
This portal is also used to distribute the Quality and Resource Use Reports. If you do not already have an Enterprise Identity Management (EIDM) account, you can set one up and get access to a “Physician Quality and Value Programs” role in preparation for accessing your field test report by using this guide.
 
Note: Your test report does not impact your 2017 MIPS reporting. This test report is for informational purposes only.  
 
Learn More
CMS is hosting two national provider calls to provide detailed information about MACRA episode-based cost measures field testing. To register, please click on the links below. Note that the same content will be covered in each call: 
Background 
MACRA requires CMS to develop episode-based cost measures to include in the MIPS Cost Performance Category. Although the Cost Performance Category does not currently impact MIPS scores, starting with 2019, federal law mandates that it counts for 30 percent of the final MIPS score. 
 
For the past year, AGA, ACG and ASGE have been actively involved in CMS’ Clinical Committee and Clinical Subcommittee on GI Disease Management, assisting in the development of this episode-based cost measure. Together, our societies will continue to ensure that implementation of MACRA is transparent and fair.  

More on Colonoscopy

Tips to Avoid a 2019 Payment Penalty

Oct. 19, 2017

Report on one measure for one patient for the 2017 Quality Payment Program Performance Year.

Closing the Colonoscopy Loophole

Oct. 4, 2017

AGA committee member Shazia Mehmood Siddique’s Philadelphia Inquirer op-ed explains how current legislation is hurting patients.

Colonoscopy Cost Measure to be Tested for MIPS

Oct. 4, 2017

Prepare now to share your thoughts on the value of the measure with CMS.